GB-001

N/A

Report date: 2025/08/18 20:01:22
NME

Base Information

Drug NameGB-001
Drug Alias NamepexopiprantADC-3680BADC-3680PTR-36GB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonistsG-protein coupled receptor antagonists
TargetsProstaglandin D2 receptor 2G-protein coupled receptor
Therapy Area/IndicationsAllergic asthmaChronic rhinosinusitis with nasal polyps (CRSwNP)Asthma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArgenta Discovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmagen TherapeuticsGb001 Inc
Active IndicationsN/A
Inactive IndicationsAllergic asthmaChronic rhinosinusitis with nasal polyps (CRSwNP)Asthma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A